Merit Medical Systems | MMSI - 销售和管理费用



金融业
股票价格
USD
资产
USD 2.86B
现金及等价物
USD 448.7M
销售成本
USD 203.68M
流动资产
USD 1.11B
流动负债
USD 264.93M
债务
USD 821.56M
EBIT
USD 60.4M
EBITDA
USD 104.39M
员工
7.4K
EPS每股收益
USD 1.19
股本和储备
USD 1.68B
销售毛利
USD 215.17M
债务利息支出
USD 12.12M
利息收入
USD 3.9M
贷款资金
USD 736.26M
市值
USD 5.08B
净收入
USD 41M
营业费用
USD 358.44M
营业利润
USD 60.4M
普通股股本
USD 59.71M
PE价格收益
32.36
税前利润
USD 53.55M
销售收入
USD 418.8M
销售和管理费用
USD 129.23M
股票
USD 374.11M
贸易债权人
USD 70.74M
应收帐款人
USD 250.9M


销售和管理费用 更改 日
3M USD 1.06B 317M 2026-06
Abbott USD 3.6B 330M 2026-06
AngioDynamics USD 36.57M 3.79M 2025-09
Anika Therapeutics USD 10.01M 14K 2025-12
AtriCure USD 82.56M 1.99M 2026-06
Baxter International USD 735M 7M 2026-06
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Boston Scientific USD 1.8B 22M 2026-06
Cooper Companies USD 676.2M 303.1M 2026-03
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
Haemonetics USD 118.94M 1.99M 2026-06
ICU Medical USD 151.92M 2.64M 2026-06
Insulet USD 344.8M 27.6M 2026-06
Integra LifeSciences USD 166.22M 12.01M 2026-06
J&J USD 6.42B 381M 2026-06
Medtronic 2.96B 9M 2025-12
Merit Medical Systems USD 129.23M 18.76M 2026-06
Olympus JPY 125.03B 14.31B 2026-06
Pfizer USD 3.41B 496M 2026-06
STAAR Surgical USD 38.64M 299K 2026-03
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 111.64M 3.45M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
Terumo JPY 109.7B 5.11B 2026-06
Zimmer Biomet Holdings USD 911.6M 61.7M 2026-06